The CHMP gives a positive opinion to Eli Lilly's Jaypirca in patients with relapsed or refractory CLL in a post-BTK inhibitor setting.

在医学界迎来了一则令人振奋的消息：全球领先的制药公司礼来宣布其研发的抗癌药物Jaypirca（吡托布鲁替尼）获得了欧洲药品管理局人用药品委员会（CHMP）的支持，该药物有望扩大用于治疗那些曾经接受过布鲁顿酪氨酸激酶抑制剂治疗后出现复发或对现有疗法反应不佳的慢性淋巴细胞白血病成人患者。这标志着在对抗这一顽固疾病方面取得了重要进展。

Following a flurry of activity at this month’s meeting of the European Medicines Agency’s Committee for Medicinal Products ...

Eli Lilly said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its Jaypirca cancer drug in certain patients with chronic lymphocytic ...

The Board of Directors of MVB Financial Corp. ("MVBF" or "MVB Financial") has announced the appointment of Vic Maculaitis as a Member of the Board. "With more than 20 years of professional experience ...

EastGroup Properties, Inc.  (the "Company", "we", "our", "us" or "EastGroup") announced today its recent business activity. As ...

Eli Lilly (LLY) and Company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive ...

In the past two years, Lilly has received approvals for several new drugs like Kisunla, Omvoh and Jaypirca. Its new drugs contributed significantly to its top-line growth in 2024. Lilly is also making ...

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after acalabrutinib and venetoclax/rituximab. JAIN: In…December 2023, pirtobrutinib ...

Overseen by the renowned immunologist Dr. Carl June, it showed the edited genes had a sustained ability to attack and kill tumors. CRISPR is a revolutionary method of gene editing that allows ...

Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Omvoh® (mirikizumab ...